Literature DB >> 15548953

SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method.

Martin Blaimer1, Felix Breuer, Matthias Mueller, Robin M Heidemann, Mark A Griswold, Peter M Jakob.   

Abstract

Fast imaging methods and the availability of required hardware for magnetic resonance tomography (MRT) have significantly reduced acquisition times from about an hour down to several minutes or seconds. With this development over the last 20 years, magnetic resonance imaging (MRI) has become one of the most important instruments in clinical diagnosis. In recent years, the greatest progress in further increasing imaging speed has been the development of parallel MRI (pMRI). Within the last 3 years, parallel imaging methods have become commercially available, and therefore are now available for a broad clinical use. The basic feature of pMRI is a scan time reduction, applicable to nearly any available MRI method, while maintaining the contrast behavior without requiring higher gradient system performance. Because of its faster image acquisition, pMRI can in some cases even significantly improve image quality. In the last 10 years of pMRI development, several different pMRI reconstruction methods have been set up which partially differ in their philosophy, in the mode of reconstruction as well in their advantages and drawbacks with regard to a successful image reconstruction. In this review, a brief overview is given on the advantages and disadvantages of present pMRI methods in clinical applications, and examples from different daily clinical applications are shown.

Mesh:

Year:  2004        PMID: 15548953     DOI: 10.1097/01.rmr.0000136558.09801.dd

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  89 in total

1.  Current CONtrolled Transmit And Receive Coil Elements (CONTAR) for Parallel Acquisition and Parallel Excitation Techniques at High-Field MRI.

Authors:  E Kirilina; A Kühne; T Lindel; W Hoffmann; K H Rhein; T Riemer; F Seifert
Journal:  Appl Magn Reson       Date:  2011-08-21       Impact factor: 0.831

2.  Derivative encoding for parallel magnetic resonance imaging.

Authors:  Jun Shen
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

3.  Improved pediatric MR imaging with compressed sensing.

Authors:  Shreyas S Vasanawala; Marcus T Alley; Brian A Hargreaves; Richard A Barth; John M Pauly; Michael Lustig
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

4.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

5.  Fast multicomponent 3D-T relaxometry.

Authors:  Marcelo V W Zibetti; Elias S Helou; Azadeh Sharafi; Ravinder R Regatte
Journal:  NMR Biomed       Date:  2020-05-02       Impact factor: 4.044

6.  Advantages and pitfalls in 3T MR brain imaging: a pictorial review.

Authors:  Bernd L Schmitz; Andrik J Aschoff; Martin H K Hoffmann; Georg Grön
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 7.  Advances in MRI tagging techniques for determining regional myocardial strain.

Authors:  Vinay M Pai; Leon Axel
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

8.  Role of standardized and study-specific human brain diffusion tensor templates in inter-subject spatial normalization.

Authors:  Shengwei Zhang; Konstantinos Arfanakis
Journal:  J Magn Reson Imaging       Date:  2012-10-03       Impact factor: 4.813

Review 9.  Current trends and challenges in MRI acquisitions to investigate brain function.

Authors:  Bradley P Sutton; Cheng Ouyang; Dimitrios C Karampinos; Gregory A Miller
Journal:  Int J Psychophysiol       Date:  2009-02-21       Impact factor: 2.997

Review 10.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.